View in EDS PDF Full Text

Outcomes on anti-VEGFR-2/paclitaxel treatment after progression on immune checkpoint inhibition in patients with metastatic gastroesophageal adenocarcinoma.

Saved in:
Bibliographic Details
Title: Outcomes on anti-VEGFR-2/paclitaxel treatment after progression on immune checkpoint inhibition in patients with metastatic gastroesophageal adenocarcinoma.
Authors: Kankeu Fonkoua LA; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.; Department of Hematology, Mayo Clinic, Rochester, Minnesota, USA., Chakrabarti S; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.; Department of Oncology, Medical College of Wisconsin, Wauwatosa, Wisconsin, USA., Sonbol MB; Department of Oncology, Mayo Clinic, Phoenix, Arizona, USA., Kasi PM; Department of Oncology, Mayo Clinic, Jacksonville, Florida, USA.; Department of Oncology, University of Iowa, Iowa City, Iowa, USA., Starr JS; Department of Oncology, Mayo Clinic, Jacksonville, Florida, USA., Liu AJ; Department of Oncology, Mayo Clinic, Phoenix, Arizona, USA., Nevala WK; Department of Hematology, Mayo Clinic, Rochester, Minnesota, USA., Maus RL; Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA., Bois MC; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA., Pitot HC; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA., Chandrasekharan C; Department of Oncology, University of Iowa, Iowa City, Iowa, USA., Ross HJ; Department of Oncology, Mayo Clinic, Phoenix, Arizona, USA., Wu TT; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA., Graham RP; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA., Villasboas JC; Department of Hematology, Mayo Clinic, Rochester, Minnesota, USA.; Department of Immune Monitoring Core, Mayo Clinic, Rochester, Minnesota, USA., Weiss M; ThedaCare Cancer Care, Appleton, Wisconsin, USA., Foster NR; Department of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA., Markovic SN; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.; Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA., Dong H; Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA.; Department of Urology, Mayo Clinic, Rochester, Minnesota, USA., Yoon HH; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.
Source: International journal of cancer [Int J Cancer] 2021 Jul 15; Vol. 149 (2), pp. 378-386. Date of Electronic Publication: 2021 Mar 26.
Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33739449
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Outcomes on anti-VEGFR-2/paclitaxel treatment after progression on immune checkpoint inhibition in patients with metastatic gastroesophageal adenocarcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kankeu+Fonkoua+LA%22">Kankeu Fonkoua LA</searchLink>; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.; Department of Hematology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Chakrabarti+S%22">Chakrabarti S</searchLink>; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.; Department of Oncology, Medical College of Wisconsin, Wauwatosa, Wisconsin, USA.<br /><searchLink fieldCode="AU" term="%22Sonbol+MB%22">Sonbol MB</searchLink>; Department of Oncology, Mayo Clinic, Phoenix, Arizona, USA.<br /><searchLink fieldCode="AU" term="%22Kasi+PM%22">Kasi PM</searchLink>; Department of Oncology, Mayo Clinic, Jacksonville, Florida, USA.; Department of Oncology, University of Iowa, Iowa City, Iowa, USA.<br /><searchLink fieldCode="AU" term="%22Starr+JS%22">Starr JS</searchLink>; Department of Oncology, Mayo Clinic, Jacksonville, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Liu+AJ%22">Liu AJ</searchLink>; Department of Oncology, Mayo Clinic, Phoenix, Arizona, USA.<br /><searchLink fieldCode="AU" term="%22Nevala+WK%22">Nevala WK</searchLink>; Department of Hematology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Maus+RL%22">Maus RL</searchLink>; Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Bois+MC%22">Bois MC</searchLink>; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Pitot+HC%22">Pitot HC</searchLink>; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Chandrasekharan+C%22">Chandrasekharan C</searchLink>; Department of Oncology, University of Iowa, Iowa City, Iowa, USA.<br /><searchLink fieldCode="AU" term="%22Ross+HJ%22">Ross HJ</searchLink>; Department of Oncology, Mayo Clinic, Phoenix, Arizona, USA.<br /><searchLink fieldCode="AU" term="%22Wu+TT%22">Wu TT</searchLink>; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Graham+RP%22">Graham RP</searchLink>; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Villasboas+JC%22">Villasboas JC</searchLink>; Department of Hematology, Mayo Clinic, Rochester, Minnesota, USA.; Department of Immune Monitoring Core, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Weiss+M%22">Weiss M</searchLink>; ThedaCare Cancer Care, Appleton, Wisconsin, USA.<br /><searchLink fieldCode="AU" term="%22Foster+NR%22">Foster NR</searchLink>; Department of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Markovic+SN%22">Markovic SN</searchLink>; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.; Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Dong+H%22">Dong H</searchLink>; Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA.; Department of Urology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Yoon+HH%22">Yoon HH</searchLink>; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220042124%22">International journal of cancer</searchLink> [Int J Cancer] 2021 Jul 15; Vol. 149 (2), pp. 378-386. <i>Date of Electronic Publication: </i>2021 Mar 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Comparative Study; Journal Article; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Liss%22">Wiley-Liss </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0042124 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-0215 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200207136%22">00207136 </searchLink><i>NLM ISO Abbreviation: </i>Int J Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33739449
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/ijc.33559
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 378
    Titles:
      – TitleFull: Outcomes on anti-VEGFR-2/paclitaxel treatment after progression on immune checkpoint inhibition in patients with metastatic gastroesophageal adenocarcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kankeu Fonkoua LA
      – PersonEntity:
          Name:
            NameFull: Chakrabarti S
      – PersonEntity:
          Name:
            NameFull: Sonbol MB
      – PersonEntity:
          Name:
            NameFull: Kasi PM
      – PersonEntity:
          Name:
            NameFull: Starr JS
      – PersonEntity:
          Name:
            NameFull: Liu AJ
      – PersonEntity:
          Name:
            NameFull: Nevala WK
      – PersonEntity:
          Name:
            NameFull: Maus RL
      – PersonEntity:
          Name:
            NameFull: Bois MC
      – PersonEntity:
          Name:
            NameFull: Pitot HC
      – PersonEntity:
          Name:
            NameFull: Chandrasekharan C
      – PersonEntity:
          Name:
            NameFull: Ross HJ
      – PersonEntity:
          Name:
            NameFull: Wu TT
      – PersonEntity:
          Name:
            NameFull: Graham RP
      – PersonEntity:
          Name:
            NameFull: Villasboas JC
      – PersonEntity:
          Name:
            NameFull: Weiss M
      – PersonEntity:
          Name:
            NameFull: Foster NR
      – PersonEntity:
          Name:
            NameFull: Markovic SN
      – PersonEntity:
          Name:
            NameFull: Dong H
      – PersonEntity:
          Name:
            NameFull: Yoon HH
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 07
              Text: 2021 Jul 15
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1097-0215
          Numbering:
            – Type: volume
              Value: 149
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: International journal of cancer
              Type: main
ResultId 1